Related Experiment Video
Updated: Sep 10, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Malignant pertussis in a young infant
1Pediatric Medical Department, Maternity and Children Hospital, Mecca, Saudi Arabia sbachal@moh.gov.sa.
Abstract:
Pertussis remains a significant threat to young infants, even in an age of widespread vaccination. In its most severe form, malignant pertussis (MP), the infection can trigger a life-threatening immune reaction, including a high white blood cell count that can place significant stress on a baby's heart and lungs. This clinical challenge is especially relevant in areas such as the Gulf Cooperation Council, where young demographics and rapidly advancing healthcare systems struggle with outbreaks that are often under-reported. In this context, we detail the case of a young infant who developed MP. The child's course was fraught with extreme leucocytosis, respiratory failure and additional bloodstream infections acquired during hospitalisation. Early recognition, aggressive supportive care and vigilant monitoring are crucial; in addition, timely maternal immunisation is the strongest defence for newborns. The successful use of hydroxyurea to manage extreme hyperleucocytosis without the need for exchange transfusion or leucapheresis is a key educational feature of this case.
Related Concept Videos
Respiratory Syncytial Virus Disease
Atypical Pneumonia
Bacterial Meningitis I: Introduction
Diphtheria
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction